Home › Funds › First Turn Management, LLC › ELVN

First Turn Management, LLC position in ELVN

ENLIVEN THERAPEUTICS INC · Health Care

First Turn Management, LLC reported holding 954,360 shares of ELVN (ENLIVEN THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$48.4M, representing 5.18% of its reported portfolio and ranking #4 among its reported holdings. First Turn Management, LLC has disclosed ELVN holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)954.36K sh
Reported value held$48.43M
Portfolio Weight5.18%
First reportedQ2 2024
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How First Turn Management, LLC's ELVN position evolved

First Turn Management, LLC first disclosed a stake in ELVN in Q2 2024 at 413,243 shares (US$9.7M). The position peaked in Q2 2026 at 954,360 shares, worth US$48.4M. Across 8 filings, First Turn Management, LLC increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q2 2026) shows 954,360 shares valued at US$48.4M — an increase of 330,521 shares quarter over quarter.. Notable position changes include a 29% increase in Q3 2024 (shares fell 12% over the following quarter), a 54% increase in Q3 2025 (shares fell 25% over the following quarter), a 53% increase in Q2 2026 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 413.24K $9.66M New
Q3 2024 535.09K $13.67M Add
Q4 2024 535.09K $12.04M Hold
Q1 2025 535.09K $10.53M Hold
Q2 2025 509.99K $10.23M Reduce
Q3 2025 783.41K $16.04M Add
Q1 2026 623.84K $24.45M New
Q2 2026 954.36K $48.43M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ELVN and 13F data

ELVN (ENLIVEN THERAPEUTICS INC) is a Health Care company. 67 other funds we track also report a position in ELVN — the largest reported positions include ORBIMED ADVISORS LLC (US$343.9M), Polar Capital Holdings Plc (US$326.4M), Vestal Point Capital, LP (US$203.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ELVN

All ELVN fund holders →

FAQ

How long has First Turn Management, LLC held ELVN?

First Turn Management, LLC has disclosed ELVN holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

What is First Turn Management, LLC's current position in ELVN?

As of Q2 2026, First Turn Management, LLC holds 954.36K shares of ELVN (ENLIVEN THERAPEUTICS INC), valued at $48.43M, representing 5.18% of its reported portfolio and ranking #4.

Has First Turn Management, LLC been buying or selling ELVN?

In the latest 13F filing (Q2 2026), First Turn Management, LLC increased its position in ELVN. The position peaked in Q2 2026 at 954.36K shares.

Which other funds hold ELVN?

Other major institutional holders of ELVN include ORBIMED ADVISORS LLC, Polar Capital Holdings Plc, Vestal Point Capital, LP, among 67 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.